Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Ray

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Medicinal Chemistry|November 25, 1994
Substrate specificity in short-chain phospholipid analogs at the active site of human synovial phospholipase A2T N Wheeler, S G Blanchard, R C Andrews, et al.
Journal of Medicinal Chemistry|July 22, 1994
6-Azasteroids: structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomeraseS V Frye, C D Haffner, P R Maloney, et al.
Organic Letters|June 3, 2000
Synthesis of ultra-short-acting neuromuscular blocker GW 0430: a remarkably stereo- and regioselective synthesis of mixed tetrahydroisoquinolinium chlorofumaratesV Samano, J A Ray, J B Thompson, et al.
Journal of Medicinal Chemistry|February 2, 1999
Bis- and mixed-tetrahydroisoquinolinium chlorofumarates: new ultra-short-acting nondepolarizing neuromuscular blockersE E Boros, E C Bigham, G E Boswell, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Medicinal Chemistry|November 25, 1994
Substrate specificity in short-chain phospholipid analogs at the active site of human synovial phospholipase A2T N Wheeler, S G Blanchard, R C Andrews, et al.
Journal of Medicinal Chemistry|July 22, 1994
6-Azasteroids: structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomeraseS V Frye, C D Haffner, P R Maloney, et al.
Organic Letters|June 3, 2000
Synthesis of ultra-short-acting neuromuscular blocker GW 0430: a remarkably stereo- and regioselective synthesis of mixed tetrahydroisoquinolinium chlorofumaratesV Samano, J A Ray, J B Thompson, et al.
Journal of Medicinal Chemistry|February 2, 1999
Bis- and mixed-tetrahydroisoquinolinium chlorofumarates: new ultra-short-acting nondepolarizing neuromuscular blockersE E Boros, E C Bigham, G E Boswell, et al.
Pageof 4